Low Level of Brain Dopamine D₂ Receptors in Methamphetamine Abusers: Association With Metabolism in the Orbitofrontal Cortex

Woolverton WL, Cervo L, Johanson CE: Effects of repeated methamphetamine administration on methamphetamine self-administration in rhesus monkeys. Pharmacol Biochem Behav 1984; 21:737-741

Peltier RL, Li DH, Lytle D, Taylor CM, Emmett-Oglesby MW: Chronic d-amphetamine or methamphetamine produces cross-tolerance to the discriminative and reinforcing stimulus effects of cocaine. J Pharmacol Exp Ther 1996; 277:212-218

Shimosato K, Ohkuma S: Simultaneous monitoring of conditioned place preference and locomotor sensitization following repeated administration of cocaine and methamphetamine. Pharmacol Biochem Behav 2000; 66:285-292

Murray JB: Psychophysiological aspects of amphetamine-methamphetamine abuse. J Psychol 1998; 132:227-237

Cho AK: Ice: a new dosage form of an old drug. Science 1990; 249:631-634

Shaw KP: Human methamphetamine-related fatalities in Taiwan during 1991-1996. J Forensic Sci 1999; 44:27-31

Munzar P, Baumann MH, Shoaib M, Goldberg SR: Effects of dopamine and serotonin-releasing agents on methamphetamine discrimination and self-administration in rats. Psychopharmacology (Berl) 1999; 141:287-296

Preston KL, Wagner GC, Schuster CR, Seiden LS: Long-term effects of repeated methylamphetamine administration on monoamine neurons in the rhesus monkey brain. Brain Res 1985; 338:243-248

Wilson JM, Kalasinsky KS, Levey AI, Bergeron C, Reiber G, Anthony RM, Schmunk GA, Shannak K, Haycock JW, Kish SJ: Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat Med 1996; 2:699-703

McCann UD, Wong DF, Yokoi F, Villemagne V, Dannals RF, Ricaurte GA: Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428. J Neurosci 1998; 18:8417-8422

Volkow ND, Fowler JS, Wolf AP, Schlyer D, Shiue CY, Albert R, Dewey SL, Logan J, Bendriem B, Christman D: Effects of chronic cocaine abuse on postsynaptic dopamine receptors. Am J Psychiatry 1990; 147:719-724

Volkow ND, Wang GJ, Fowler JS, Logan J, Hitzemann RJ, Ding YS, Pappas N, Shea C, Piscani K: Decreases in dopamine receptors but not in dopamine transporters in alcoholics. Alcohol Clin Exp Res 1996; 20:1594-1598

Volkow ND, Wang G-J, Fowler JS, Logan J, Gatley SJ, Hitzemann R, Chen AD, Pappas N: Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature 1997; 386:830-833

Wang G-J, Volkow ND, Fowler JS, Logan J, Hitzemann RJ, Pappas NS, Piscani K: Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone precipitated withdrawal. Neuropsychopharmacology 1997; 16:174-182

Volkow ND, Fowler JS, Wang G-J, Hitzemann R, Logan J, Schlyer D, Dewey S, Wolf AP: Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 1993; 14:169-177

Baxter LR, Phelps ME, Mazziotta J: Local cerebral glucose metabolic rates in obsessive compulsive disorder: a comparison with rates in unipolar depression and normal controls. Arch Gen Psychiatry 1987; 44:211-218

Insel TR: Towards a neuroanatomy of obsessive-compulsive disorder. Arch Gen Psychiatry 1992; 49:739-744

Volkow ND, Ding Y-S, Fowler JS, Wang G-J: Cocaine addiction: hypothesis derived from imaging studies with PET. J Addict Dis 1996; 15:55-71

Volkow ND, Fowler JS: Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb Cortex 2000; 10:318-325

Volkow ND, Fowler JS, Wang G-J, Dewey SL, Schlyer D, MacGregor R, Logan J, Alexoff D, Shea C, Hitzemann R, Angrist B, Wolf AP: Reproducibility of repeated measures of 11C raclopride binding in the human brain. J Nucl Med 1993; 34:609-613

Wang GJ, Volkow ND, Roque CT, Cestaro VL, Hitzemann RJ, Cantos EL, Levy AV, Dhawan AP: Functional significance of ventricular enlargement and cortical atrophy in normals and alcoholics as assessed by PET, MRI and neuropsychological testing. Radiology 1992; 186:59-65

Logan J, Fowler JS, Volkow ND, Wolf AP, Dewey SL, Schlyer D, MacGregor RR, Hitzemann R, Bendriem B, Gatley SJ, Christman DR: Graphical analysis of reversible binding from time activity measurements. J Cereb Blood Flow Metab 1990; 10:740-747

Logan J, Volkow ND, Fowler JS, Wang G-J, Dewey SL, MacGregor R, Schlyer D, Gatley SJ, Pappas N, King P, Hitzemman R, Vitkun S: Effects of blood flow on [11C] raclopride binding in the brain: model simulations and kinetic analysis of PET data. J Cereb Blood Flow Metab 1994; 14:995-1010

Hume SP, Lammertsma AA, Myers R, Rajeswaran S, Bloomfield PM, Ashworth S, Fricker RA, Torres EM, Watson I, Jones T: The potential of high-resolution positron emission tomography to monitor striatal dopaminergic function in rat models of disease. J Neurosci Methods 1996; 67:103-112

Kokoshka JM, Vaughan RA, Hanson GR, Fleckenstein AE: Nature of methamphetamine-induced rapid and reversible changes in dopamine transporters. Eur J Pharmacol 1998; 361:269-275

Gatley SJ, Volkow ND, Pyatt B, Gifford AN: Effects of methamphetamine on neurochemistry and behavior (abstract). Abstr Soc Neurosci 2000; 26:196

Cadet JL, Ladenheim B, Hirata H: Effects of toxic doses of methamphetamine (METH) on dopamine D1 receptors in the mouse brain. Brain Res 1998; 786:240-242

Robinson TE, Yew J, Paulson PE, Camp DM: The long-term effects of neurotoxic doses of methamphetamine on the extracellular concentration of dopamine measured with microdialysis in striatum. Neurosci Lett 1990; 110:193-198

Giros B, Jaber M, Jones SR, Wightman RM, Caron MG: Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 1996; 379:606-612

Volkow ND, Wang G-J, Fowler JS, Logan J, Gatley SJ, Gifford A, Hitzemann R, Ding Y-S, Pappas N: Prediction of reinforcing responses to psychostimulants in humans by brain dopamine D2 receptor levels. Am J Psychiatry 1999; 156:1440-1443

Volkow ND, Wang G-J, Fowler JS, Logan J, Schlyer D, Hitzemann R, Lieberman J, Angrist B, Pappas N, MacGregor R, Burr G, Cooper T, Wolf AP: Imaging endogenous dopamine competition with [11C]raclopride in the human brain. Synapse 1994; 16:255-262

Volkow ND, Wang G-J, Fowler JS, Logan J, Gatley SJ, Hitzemann R, Chen AD, Pappas N: Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature 1997; 386:830-833

Hietala J, West C, Syvalahti E, Nagren K, Lehikoinen P, Sonninen P, Ruotsalainen U: Striatal D2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence. Psychopharmacology (Berl) 1994; 116:285-290

Wang G-J, Volkow ND, Logan J, Pappas NR, Wong CT, Zhu W, Netusil N, Fowler JS: Brain dopamine and obesity. Lancet 2001; 3:354-357

Haber SN, Kunishio K, Mizobuchi M, Lynd-Balta E: The orbital and medial prefrontal circuit through the primate basal ganglia. J Neurosci 1995; 15:4851-4867

Ray JP, Price JL: The organization of projections from the mediodorsal nucleus of the thalamus to orbital and medial prefrontal cortex in macaque monkeys. Comp Neurol 1993; 337:1-31

Koob GF, Bloom FE: Cellular and molecular mechanisms of drug dependence. Science 1988; 242:715-723

Oades RD, Halliday GM: Ventral tegmental (A10) system: neurobiology, 1: anatomy and connectivity. Brain Res 1987; 434:117-165

Tucker DM, Luu P, Pribram KH: Social and emotional self-regulation. Ann NY Acad Sci 1995; 769:213-239

Tremblay L, Schultz W: Relative reward preference in primate orbitofrontal cortex. Nature 1999; 398:704-708

Butter CM, Mishkin M, Rosvold HE: Conditioning and extinction of a food rewarded response after selective ablations of frontal cortex in rhesus monkeys. Exp Neurol 1963; 7:65-67

Johnson TN: Topographic projections in the globus pallidus and the substantia nigra of selectively placed lesions in the precommissural caudate nucleus and putamen in the monkey. Exp Neurol 1971; 33:584-596

Schoenbaum G, Chiba AA, Gallagher M: Orbitofrontal cortex and basolateral amygdala encode expected outcomes during learning. Nat Neurosci 1998; 1:155-159

Hugdahl K, Berardi A, Thompson WL, Kosslyn SM, Macy R, Baker DP, Alpert NM, LeDoux JE: Brain mechanisms in human classical conditioning: a PET blood flow study. Neuroreport 1995; 6:1723-1728

Brown EE, Robertson GS, Fibiger HC: Evidence for conditional neuronal activation following exposure to a cocaine-paired environment: role of forebrain limbic structures. Neuroscience 1992; 12:4112-4121

Isaac WL, Nonneman AJ, Neisewander J, Landers T, Bardo MT: Prefrontal cortex lesions differentially disrupt cocaine-reinforced conditioned place preference but not conditioned taste aversion. Behav Neurosci 1989; 103:345-355

O’Brien CP, Childress AR, Ehrman R, Robbins SJ: Conditioning factors in drug abuse: can they explain compulsion? Psychopharmacology (Berl) 1998; 12:15-22

McKay JR: Studies of factors in relapse to alcohol, drug and nicotine use: a critical review of methodologies and findings. J Stud Alcohol 1999; 60:566-576

Volkow ND, Wang G-J, Fowler JS, Hitzemann R, Angrist B, Gatley SJ, Logan J, Ding Y-S, Pappas N: Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: implications in addiction. Am J Psychiatry 1999; 156:19-26

Grant S, London ED, Newlin DB, Villemagne VL, Liu X, Contoreggi C, Phillips RL, Kimes AS, Margolin A: Activation of memory circuits during cue-elicited cocaine craving. Proc Natl Acad Sci USA 1996; 93:12040-12045

Wang G-J, Volkow ND, Fowler JS, Cervany P, Hitzemann RJ, Pappas N, Wong CT, Felder C: Regional brain metabolic activation during craving elicited by recall of previous drug experiences. Life Sci 1999; 64:775-784